Survey of the Drugs Remaining in the Diskhaler and Investigation of Cleaning of Fluticasone Propionate

被引:0
|
作者
Shi-Nozawa, Reiko [1 ]
Fujita, Ken [3 ]
Ise, Yuya [2 ]
Katayama, Shirou [2 ]
Takeuchi, Koichi [1 ]
机构
[1] Meiji Pharmaceut Univ, Grad Sch, Dept Clin Pharmacol, Tokyo 2048588, Japan
[2] Nippon Med Coll Hosp, Dept Pharmaceut Serv, Bunkyo Ku, Tokyo 1138603, Japan
[3] Meiji Pharmaceut Univ, Grad Sch, Course Clin Pharm, Tokyo 2048588, Japan
关键词
inhaled corticosteroid; drug residue; cleaning; fluticasone propionate (FP); lactose; diskhaler;
D O I
10.1248/yakushi.129.365
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
When a fluticasone propionate (FP) diskhaler is used to administer inhaled corticosteroid, it has been reported that there is considerable drug residue remaining in the diskhaler after use. The internal structure of the diskhaler is complex, and it is possible that sufficient cleaning of the device is not achieved using the attached brush. In this study, the diskhaler cleaning method was examined using a patient questionnaire. In response to the question on cleaning, 56.3% of patients responded "Having done", and 66.7% responded to the question on the frequency of the cleaning, "When I use it". Furthermore, cleaning by a healthy volunteer was examined using Rotadisk (R) for inhalation practice. When the group that did not perform cleaning was compared with the group that performed cleaning with the brush, the amount of the lactose adhesion was significantly lower in the cleaning group. When the no-cleaning group was compared with the group that shook off the excess residue from the tray and the main body of the diskhaler, the group that shook off the diskhaler components showed a significantly lower amount of lactose adhesion. It was confirmed that drug residue were able to accumulate, and the shaking off method appeared to have an effect equal to that of cleaning with the brush. It seems that providing patients with guidance not only about the method of inhaling with the diskhaler but also about cleaning of the device is an important area of pharmacy patient management.
引用
收藏
页码:365 / 372
页数:8
相关论文
共 29 条
  • [11] Absorption Kinetics after Inhalation of Fluticasone Propionate via the Diskhaler®, Diskus® and Metered-Dose Inhaler in Healthy Volunteers
    Charles Brindley
    Christine Falcoz
    Alison E. Mackie
    Alan Bye
    Clinical Pharmacokinetics, 2000, 39 : 1 - 8
  • [12] A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler
    Grahnen, A
    Jansson, B
    Brundin, RM
    LingAndersson, A
    Lonnebo, A
    Johansson, M
    Eckernas, SA
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 52 (04) : 261 - 267
  • [13] A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler
    Agertoft, L
    Pedersen, S
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (06) : 773 - 780
  • [14] Analysis of relationship between peak inspiratory flow rate and amount of drug delivered to lungs following inhalation of fluticasone propionate with a Diskhaler
    Yokoyama, Haruko
    Yamamura, Yoshikazu
    Ozeki, Takeshi
    Iga, Tatsuji
    Yamada, Yasuhiko
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2007, 30 (01) : 162 - 164
  • [15] Fluticasone propionate via the Diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness
    Langley, SJ
    Holden, J
    Derham, A
    Hedgeland, P
    Sharma, RK
    Woodcock, A
    CHEST, 2002, 122 (03) : 806 - 811
  • [16] A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler
    A. Grahnén
    B. Jansson
    R. M. Brundin
    A. Ling-Andersson
    A. Lönnebo
    M. Johansson
    S.-Å. Eckernäs
    European Journal of Clinical Pharmacology, 1997, 52 : 261 - 267
  • [17] Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma
    Galant, SP
    van Bavel, J
    Finn, A
    Gross, G
    Pleskow, W
    Brown, A
    Hamedani, AG
    Harding, SM
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1999, 82 (03) : 273 - 280
  • [18] Pharmacokinetics of fluticasone propionate inhaled from the Diskhaler(R) and the Diskus(R) after repeat doses in healthy subjects and asthmatic patients.
    Falcoz, C
    Mackie, AE
    Moss, J
    Horton, J
    Ventresca, GP
    Brown, A
    Field, E
    Harding, SM
    Wire, P
    Bye, A
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 99 (01) : 2041 - 2041
  • [19] Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma
    Condemi, JJ
    Chervinsky, P
    Goldstein, MF
    Ford, LB
    Berger, WE
    Ayars, GH
    Rogenes, PR
    Edwards, L
    Pepsin, PJ
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1997, 100 (04) : 467 - 474
  • [20] Fluticasone propionate dry powder via the diskus or diskhaler is safe and effective in pediatric patients aged 4-5 with moderate persistent asthma.
    Rupp, TT
    Hendricks, VL
    Hamedani, AG
    House, KW
    Harding, SM
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : S12 - S12